Endothelial progenitor cells and atherosclerosis

Harefuah

Volumn 145, Issue 5 SPEC. ISS., 2006, Pages 358-361

  Hamed, Saher ^a   Roguin, Ariel ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Atherosclerosis; Cardiovascular disease; Diabetes; Endothelial progenitor cells

Indexed keywords

ATHEROSCLEROSIS; CYTOLOGY; HUMAN; PATHOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33746930879     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Bitzur R, Harats D & Rubinstein A, Guidelines for the prevention and treatment of atherosclerosis and cardiovasculer diseases: treatment of diabetes mellitus, dyslipidemia and the prevention of stroke. Harefuah, 2005; 144: 647-54.
2. Asahara T, Murohara T, Sullivan A & al, Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997; 275: 964-67.
3. Asahara T, Masuda H, Takahashi T & al, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res, 1999; 85: 221-228.
4. Rafii S & Lyden D, Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med, 2003; 9: 702-712.
5. Rehman J, Li J, Orschell CM & March KL, Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 2003; 107: 1164-1169.
6. Orlic D, Kajstura J, Chimenti S & al, Bone marrow cells regenerate infarcted myocardium. Nature, 2001; 410: 701-705.
7. Wollert KC, Meyer GP, Lotz J & al, Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet, 2004; 364: 141-148.
8. Yamamoto K, Kondo T, Suzuki S & al, Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol, 2004; 24: e192-e196.
9. Kawamoto A, Gwon HC, Iwaguro H & al, Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation, 2001; 103: 634-37.
10. Assmus B, Schachinger V, Teupe C & al, Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation, 2002; 106: 3009-17.
11. Kalka C, Masuda H, Takahashi T & al, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000; 97: 3422-27.
12. Ingram DA, Mead LE, Tanaka H & al, Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 2004; 104: 2752-2760.
13. Hill JM, Zalos G, Halcox JP & al, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003; 348: 593-600.
14. Crosby JR, Kaminski WE, Schatteman G & al, Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res, 2000; 87: 728-730.
15. Werner N, Kosiol S, Schiegl T & al, Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med, 2005; 353: 999-1007.
16. Schmidt-Lucke C & Rossig L, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the chnical importance of endogenous vascular repair. Circulation, 2005; 111: 2981-87.
17. Vasa M, Fichtischerer S, Aicher A & al, Number and migratory activity of circulating endothehal progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 2001; 89: E1-E7.
18. Imanishi T, Hano T & Nishio I, Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res, 2004; 27: 101-108.
19. Min TQ, Zhu CJ, Xiang WX & al, Improvement in endothehal progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther, 2004; 18: 203-209.
20. Tepper OM, Galiano RD, Capla JM & al, Human endothehal progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 2002; 106: 2781-2786.
21. Krankel N, Adams V, Linke A & al, Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol, 2005; 25: 698-703.
22. Chen JZ, Zhang FR, Tao QM & al, Number and activity of endothehal progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond), 2004; 107: 273-280.
23. Dimmeler S, Aicher A, Vasa M & al, HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-ki-nase/Akt pathway. J Clin Invest, 2001; 108: 391-397.
24. Kondo T, Hayashi M, Takeshita K & al, Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol, 2004; 24: 1442-1447.
25. Wang X, Zhu J, Chen J & Shang Y, Effects of nicotine on the number and activity of circulating endothelial progenitor cells. J Clin Pharmacol, 2004; 44: 881-889.
26. Laufs U, Wassmann S, Czech T & al, Physical inactivity increases oxidative stress, endothehal dysfunction,and atherosclerosis. Arterioscler Thromb Vasc Biol, 2005; 25: 809-814.
27. Sandri M, Adams V, Gielen S & al, Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation, 2005; 111: 3391-3399.
28. Ghani U, Shuaib A, Salam A & al, Endothehal progenitor cells during cerebrovascular disease. Stroke, 2005; 36: 151-153.